Source the Best PseudoUridines at Industry-Renowned Exhibitions

BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022. With only a few days away, BOC Sciences sincerely invites all researchers concerned to pay a visit to its booths and have a constructive conversation with its knowledgeable experts.

Scale-Up Facilities and Leading Expertise Drive Commercial Fermentation Progress

BOC Sciences provides high-quality antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other fermented products as well as comprehensive CDMO services.

ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Technology

ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment As a part of the LifeSphere® platform, this solution will be named LifeSphere Clarity and will unlock crucial data patterns leveraging machine learning Rapid, robust benefit-risk assessment is key for all organizations collecting and processing large safety data sets Intelligent tool will drive industry-wide advancement of pharmacovigilance and patient safety capabilities

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions

The American College of Cardiology (ACC) is leveraging Biofourmis’ AI-based predictive analytics platform and virtual health navigators for ACC’s TRANSFORM(3) study. The study—which focuses on underserved populations with a history of healthcare disparities—will evaluate different intervention strategies for improving adherence to guideline-directed medication therapy (GDMT) for managing specific chronic cardiovascular conditions.

SeekGene Increases Efficiency by 500% by Leveraging MemVerge Memory Machine in the Cloud

SeekGene, a biotechnology research firm focusing on single-cell technology, has significantly reduced processing time and cost for data intensive single-cell analysis tasks using MemVerge Memory Machine running on AliCloud i4p compute instances. As a result, SeekGene is able to cut analytical time and costs significantly while optimizing their single-cell sequencing capabilities for researchers worldwide to promote faster development of precision medicine.

Absolute Antibody to be featured on “World’s Greatest!...” television series

NEWS RELEASE: Emmes launches Advantage eClinical

Please find below the latest news story from Emmes (CRO) announcing the launch of its Advanatge eClinical as a standalone cloud native clinical technology platform – after more than two years in development. Unusually, the new platform will be available to both Emmes and non-Emmes customers and aims to increase access to a suitable platform particularly for smaller biotechs. Should you have any questions or would like to run a Q&A around this news, please do let me know.

Biolog Announces New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products

Biolog has appointed a new leadership team and secured a major investment to help drive widespread adoption of its industry-leading microbial identification and phenotypic profiling products

Domainex appoints Dr Scott Martin as Analytical and Bioanalytical Group Leader

Domainex Ltd, a leading integrated medicines research services partner, is pleased to announce that Dr Scott Martin has been appointed Analytical and Bioanalytical Group Leader with immediate effect.

Global CRO to Showcase Respiratory Expertise at 2022 ATS International Conference

Rho, a global full-service contract research organization (CRO), will showcase its expertise in pulmonary and respiratory related illnesses with attendees during the 2022 American Thoracic Society (ATS) International Conference, taking place at the Moscone Center in San Francisco, May 13-18. Rho experts will be at booth #2203 to share their knowledge of the latest advances in the rapidly evolving field of pulmonary medicine, some of which include asthma, COPD and cystic fibrosis. They will be available for one-on-one interviews during the conference with those interested in learning more about Rho’s industry developments.

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation’s leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon’s machine learning neuroanalytics platform.

physIQ Announces Two New Appointments to Executive Leadership Team to Advance Digital Health Market Commercialization

A leader in digital medicine, physIQ today announced the appointment of two new members to its executive leadership team to accelerate the organization’s commercialization strategy and growth trajectory. John Wilson has been named Senior Vice President and General Manager of Life Sciences, and Chris Englerth joins the team as Vice President of Marketing.

Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance

Faculty Opinions makes the insights and article recommendations from its global network of life sciences and medical experts free-to-access

Faculty Opinions, an H1 community and global research curation and recommendation service, has announced it is making its article recommendations free-to-access to current and new users via its platform.

Cotiviti Client Conference Brings Together Leading Payer Executives to Explore Solutions for Improving the Healthcare System Through Innovation, Technology, and Analytics

Chairman, President, and CEO Emad Rizk, M.D. to deliver keynote on strategies to reduce inefficiency and complexity in the healthcare system and the transition to value-based care

Ashfield Engage acquires ‘smart data’ organization PROPENSITY4

Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey

Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey Bracknell, UK: 9 May 2022 – mdgroup, the leading global provider of healthcare technologies and personalised clinical study services, are transforming the clinical trial ecosystem with the launch of its enterprise solution Primarius3.

RHO HONORED AS SILVER STEVIE® AWARD WINNER IN 2022 AMERICAN BUSINESS AWARDS®

Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, was named the winner of a Silver Stevie® Award in the Fastest Growing Company of the Year category in the 20th Annual American Business Awards®.

CARLSBAD, Calif. (May 2, 2022) – 384-well Option Now Available for Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System

For your product news coverage, I wanted to share the latest product launch from Thermo Fisher Scientific. After introducing the new Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System last November, Thermo Fisher has now introduced a 384-well option for the IVD system. Users can easily interchange between the 96-well and 384-23ll blocks, providing greater flexibility for assay design and molecular diagnostic testing.